Invivyd IVVD
NASDAQ IVVD
$0.67 +0.04 (+5.55%)
As of: Oct 21, 2026 · 11:40 AM EDT

Invivyd (IVVD) EBIT Margin (2024 - 2026)

Updated

Invivyd's EBIT Margin came in at -320.76% for Q2 2026, down 192.98 percentage points from -127.78% a year earlier.

Analysis

Invivyd (IVVD) EBIT Margin (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Invivyd reported EBIT Margin of -149.73%, up 95.94 percentage points year-over-year; for FY2025, it came in at -103.99%, up 592.81 percentage points from FY2024.

  • Going back by year, EBIT Margin was -696.80% in FY2024.
  • The Q2 2026 figure represents the lowest quarterly EBIT Margin since Q3 2024.
  • Year-over-year, EBIT Margin increased in three of the last four quarters, with an average year-over-year change of +626.67 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.21%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 37.86%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 20.57%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -133.21%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 28.37%
10 Invivyd 215.94 Mn -290.70 Mn 13.01 Mn -320.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -320.76%
Dec 31, 2025 -72.96%
Sep 30, 2025 -83.96%
Jun 30, 2025 -127.78%
Mar 31, 2025 -149.70%
Dec 31, 2024 -139.14%
Sep 30, 2024 -670.01%
Jun 30, 2024 -2,175.22%
API Access

Invivyd EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY